SEC Comment Letter 0000000000-23-004343 to LEAP THERAPEUTICS, INC. (LPTX) (CIK 0001509745) (CYPH)
LEAP THERAPEUTICS, INC. (LPTX) (CIK 0001509745)
Date: April 27, 2023 · CIK: 0001509745 · Accession: 0000000000-23-004343
AI Filing Summary & Sentiment
File numbers found in text: 333-271399
Letter
United States securities and exchange commission logo April 27, 2023 Douglas Onsi Chief Executive Officer LEAP THERAPEUTICS, INC. 47 Thorndike Street, Suite B1-1 Cambridge, MA 02141 Re:LEAP THERAPEUTICS, INC. Registration Statement on Form S-3 Filed April 21, 2023 File No. 333-271399 Dear Douglas Onsi : This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Julio Vega
Show Raw Text
United States securities and exchange commission logo
April 27, 2023
Douglas Onsi
Chief Executive Officer
LEAP THERAPEUTICS, INC.
47 Thorndike Street, Suite B1-1
Cambridge, MA 02141
Re:LEAP THERAPEUTICS, INC.
Registration Statement on Form S-3
Filed April 21, 2023
File No. 333-271399
Dear Douglas Onsi :
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Julio Vega